What this trial studies
Health promotion is defined as the behaviors that a person exhibits for a long-term and high-standard life. Health promotion creates a sense of health in the individual, which makes the person feel more energetic and happy. The health promotion model primarily aims to treat the disease in the person. If the individual does not have a disease, their health is further improved.
Conditions in scope
- Absence of Menstrual Bleeding for at Least 12 Consecutive Months
- No Communication Difficulties
- Using a Mobile Phone
- Becoming Literate
- Not Using Sleeping Pills
- Not Taking Any Supplements to Sleep
Interventions
- sleep hygiene education (Behavioral) — This study will be conducted to examine the effects of sleep hygiene training, which is given to women in menopause to eliminate sleep problems and menopause symptoms that they often experience, on sleep and menopause symptoms experienced by women.
Who can join
Women only · Ages 45 Years to 59 Years · Accepts healthy volunteers.
Inclusion criteria
- Not having menstrual bleeding for at least 12 consecutive months
- Not having difficulty communicating
- Using a mobile phone
- Being literate
- Not using sleeping pills
- Not taking any supplements to sleep.
Exclusion criteria
- Menstrual bleeding during the research period
- The participant wants to talk about his/her research.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Malatya | Malatya | Inonu University | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2024-02-01
- Primary completion: 2024-03-31
- Last update posted: 2026-04-01
- First posted: 2025-05-28
Sponsor & contact
Lead sponsor: Inonu University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Pittsburgh Sleep Quality Index (first day encountered)
It was developed by Buysse et al. (1989) to assess sleep quality. It was adapted to Turkish by Ağargün et al. in 1996. The PSQI assesses the quality of an individual's sleep in the last month. While the individual answers 19 of the 24 questions in the PSQI, 5 questions are expected to be answered by the spouse or a… - Menopausal Symptoms Assessment Scale (first day encountered)
MSDÖ, developed by Schneider and colleagues in German to determine the level of menopause experienced by women, was translated and adapted into Turkish by Gürkan in 2005. The Likert-type scale consists of a total of 11 items covering menopausal complaints. Each item has three sub-dimensions, with the options 0: none at all, 1: mild, 2: moderate, 3: severe and 4:…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06991660 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.